GoodRx Holdings, Inc. will release its second quarter 2026 financial results after U.S. markets close on Wednesday, August 5, 2026. The company's management will discuss the results and its business outlook during a conference call and webcast the following morning. This announcement provides investors with a timeline to assess the prescription savings platform's performance for the quarter.

Conference Call Details

The conference call is scheduled for Thursday, August 6, 2026, at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time). Investors interested in participating must pre-register via the provided link to receive dial-in details and a unique passcode. The call will also be webcast live on the company's investor relations website, where accompanying materials will be posted prior to the event.

Access and Archive

Following the live event, an archived version of the webcast will be available on GoodRx's investor relations website approximately one hour after the call concludes. The archive will remain accessible for at least 30 days, allowing stakeholders to review the discussion at their convenience.

Key Dates

GoodRx intends to use its investor relations website as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. Investors are encouraged to consult the website regularly for important information in addition to following press releases and SEC filings.